Jay Feingold - Oct 7, 2021 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role: Chief Medical Officer
Signature: /s/ Pamela Connealy, Attorney-in-Fact for Jay Feingold
Stock symbol: PYXS
Transactions as of: Oct 7, 2021
Transactions value $: $0
Form type: 4
Date filed: 10/12/2021, 07:47 PM
Next filing: Apr 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PYXS	Common Stock	Award	$0	+43.8K		$0.00	43.8K	Oct 7, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PYXS	Stock Option (Right to buy)	Award	$0	+437K		$0.00	437K	Oct 7, 2021	Common Stock	437K	$16.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock that vest 25% of the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F2	These stock options vest 25% on the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.